PRODUCT LITERATURE
Bioequivalence Study of Modified Release Formulation (MRF) of Loratadine and Pseudoephedrine Fixed Combination
The present study was conducted to find out whether the bioavailability of PT Dexa Medica’s modified-release formulation (MRF) of pseudoephedrine and loratadine fixed combination (Rhinos®SR) was comparable to that produced by the reference’s company. The pharmacokinetic parameters assessed in this study were area under the serum concentration - time curve during one dosing interval (AUC0-12h), peak serum concentration of the drug (Cmax), trough serum concentration, i.e., concentration at the end of the dosing
interval (Cmin), average serum concentration, i.e., average serum concentration during one dosing interval (Cav), the fluctuation index (FI) and swing, at steady-state
No other version available